BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pilipow K, Darwich A, Losurdo A. T-cell-based breast cancer immunotherapy. Semin Cancer Biol 2021;72:90-101. [PMID: 32492452 DOI: 10.1016/j.semcancer.2020.05.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Fuentes-Antrás J, Guevara-Hoyer K, Baliu-Piqué M, García-Sáenz JÁ, Pérez-Segura P, Pandiella A, Ocaña A. Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine. Front Oncol 2020;10:605633. [PMID: 33194771 DOI: 10.3389/fonc.2020.605633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Montironi C, Muñoz-Pinedo C, Eldering E. Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions. Cancers (Basel) 2021;13:284. [PMID: 33466674 DOI: 10.3390/cancers13020284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang M, Wei Y, Li Y, Li H, Jin J, Lu Y, Li Q. Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism. Immun Inflamm Dis 2022;10:e626. [PMID: 35894707 DOI: 10.1002/iid3.626] [Reference Citation Analysis]
4 Wang X, Xiao Z, Gong J, Liu Z, Zhang M, Zhang Z. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside. Transl Lung Cancer Res 2021;10:167-82. [PMID: 33569302 DOI: 10.21037/tlcr-20-822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Toulouie S, Johanning G, Shi Y. Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges. J Cancer 2021;12:1212-9. [PMID: 33442419 DOI: 10.7150/jca.54095] [Reference Citation Analysis]
6 Chen Y, Pal S, Hu Q. Recent advances in biomaterial-assisted cell therapy. J Mater Chem B 2022. [PMID: 35612089 DOI: 10.1039/d2tb00583b] [Reference Citation Analysis]
7 Munkácsy G, Santarpia L, Győrffy B. Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment Features. Biomedicines 2022;10:248. [PMID: 35203458 DOI: 10.3390/biomedicines10020248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Salemme V, Centonze G, Cavallo F, Defilippi P, Conti L. The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy. Front Oncol 2021;11:610303. [PMID: 33777750 DOI: 10.3389/fonc.2021.610303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zhu J, Huang R, Yang R, Xiao Y, Yan J, Zheng C, Xiao W, Huang C, Wang Y. Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration. Cancer Cell Int 2021;21:529. [PMID: 34641869 DOI: 10.1186/s12935-021-02223-0] [Reference Citation Analysis]